Aamna AlShehhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aamna AlShehhi has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Kinda Khalaf
Khalifa University
8 shared publications - Abdul Aziz Hulleck
Department of Mechanical Engineering, Khalifa University, Abu Dhabi, UAE
7 shared publications - Leontios J. Hadjileontiadis
Khalifa University
7 shared publications - Rateb Katmah
Department of Biomedical Engineering and Biotechnology, Khalifa University, Abu Dhabi, United Arab Emirates
7 shared publications Sherlyn Jemimah
Affiliation Department of Biomedical Engineering and Biotechnology, Khalifa University, Abu Dhabi, United Arab Emirates
6 shared publicationsFerial Abuhantash
Department of Biomedical Engineering & Biotechnology, Khalifa University, Abu Dhabi, United Arab Emirates
5 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Wiley in Small Structures
- Vol. 7 (10)
Cover Feature: Stress‐Programmed Microcrack Networks in Gallium–Carbon Nanotube Thin Films for Plasma‐Active and Electroresponsive Antibacterial Interfaces (Small Struct. 10/2026)
- 21 October 2026
- Published by Wiley in Small Structures
- Vol. 7 (10)
Open AccessCover Feature: Stress‐Programmed Microcrack Networks in Gallium–Carbon Nanotube Thin Films for Plasma‐Active and Electroresponsive Antibacterial Interfaces (Small Struct. 10/2026)
- Open Access
- 17 October 2026
- Published by Wiley in Small Structures
- Vol. 7 (10)
Stress‐Programmed Microcrack Networks in Gallium–Carbon Nanotube Thin Films for Plasma‐Active and Electroresponsive Antibacterial Interfaces
Liquid‐metal conductors promise metallic conductivity with tissue‐like compliance, yet their translation into ultrathin functional films is limited by uncontrolled flow, coalescence, and loss of pattern fidelity under deformation. Here, we show that mechanical stress can program the microstructure of gallium–carbon nanotube (Ga/CNT) films into electroactive architectures. Drying‐induced tensile stress and rolling‐assisted sintering generate hierarchical microcrack networks that partition gallium into confined conductive microdomains while preserving mechanically repairable electrical pathways. CNT loading defines a structure–property trade‐off: low CNT content stabilizes gallium thin films and maintains high conductivity under bending, folding, and fracture, whereas intermediate CNT loading produces microcrack‐rich surfaces. Crack edges and junctions are proposed to act as distributed electroactive sites that localize the electric field: atmospheric plasma emission intensifies with crack density, and low‐voltage stimulation potentiates antibacterial activity with elevated intracellular reactive oxygen species. The resulting Ga/CNT films inactivate Gram‐positive and Gram‐negative bacteria while maintaining human keratinocyte compatibility under the tested in vitro conditions. This work establishes stress‐programmed microcracking as a route for transforming gallium composites from passive deformable conductors into plasma‐active and electroresponsive antibacterial interfaces.
- 17 October 2026
- Published by Wiley in Small Structures
- Vol. 7 (10)
Open AccessStress‐Programmed Microcrack Networks in Gallium–Carbon Nanotube Thin Films for Plasma‐Active and Electroresponsive Antibacterial Interfaces
Liquid‐metal conductors promise metallic conductivity with tissue‐like compliance, yet their translation into ultrathin functional films is limited by uncontrolled flow, coalescence, and loss of pattern fidelity under deformation. Here, we show that mechanical stress can program the microstructure of gallium–carbon nanotube (Ga/CNT) films into electroactive architectures. Drying‐induced tensile stress and rolling‐assisted sintering generate hierarchical microcrack networks that partition gallium into confined conductive microdomains while preserving mechanically repairable electrical pathways. CNT loading defines a structure–property trade‐off: low CNT content stabilizes gallium thin films and maintains high conductivity under bending, folding, and fracture, whereas intermediate CNT loading produces microcrack‐rich surfaces. Crack edges and junctions are proposed to act as distributed electroactive sites that localize the electric field: atmospheric plasma emission intensifies with crack density, and low‐voltage stimulation potentiates antibacterial activity with elevated intracellular reactive oxygen species. The resulting Ga/CNT films inactivate Gram‐positive and Gram‐negative bacteria while maintaining human keratinocyte compatibility under the tested in vitro conditions. This work establishes stress‐programmed microcracking as a route for transforming gallium composites from passive deformable conductors into plasma‐active and electroresponsive antibacterial interfaces.
- Open Access
- 27 January 2026
- Published by Springer Nature in BioData Mining
- Vol. 19 (1)
Explainable AI-driven graph-based neural networks for mucopolysaccharidoses diagnosis
Mucopolysaccharidoses (MPS) are a group of rare lysosomal storage disorders caused by enzyme deficiencies leading to the accumulation of glycosaminoglycans
- 27 January 2026
- Published by Springer Nature in BioData Mining
- Vol. 19 (1)
Open AccessExplainable AI-driven graph-based neural networks for mucopolysaccharidoses diagnosis
Mucopolysaccharidoses (MPS) are a group of rare lysosomal storage disorders caused by enzyme deficiencies leading to the accumulation of glycosaminoglycans
- Open Access
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Comparison of machine learning models for mucopolysaccharidosis early diagnosis using UAE medical records
Rare diseases, such as Mucopolysaccharidosis (MPS), present significant challenges to the healthcare system. Some of the most critical challenges are the delay and the lack of accurate disease diagnosis. Early diagnosis of MPS is crucial, as it has the potential to significantly improve patients’ response to treatment, thereby reducing the risk of complications or death. This study evaluates the performance of different machine learning (ML) models for MPS diagnosis using electronic health records (EHR) from the Abu Dhabi Health Services Company (SEHA). The retrospective cohort comprises 115 registered patients aged \(\le\) 19 Years old from 2004 to 2022. Using nested cross-validation, we trained different feature selection algorithms in combination with various ML algorithms and evaluated their performance with multiple evaluation metrics. Finally, the best-performing model was further interpreted using feature contributions analysis methods such as Shapley additive explanations (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME). We found that Naive Bayes trained on the domain expert selected features reported a superior performance with an accuracy of 0.93 (0.08), AUC of 0.96 (0.04), F1-score of 0.91 (0.1), and MCC of 0.86 (0.16). SHAP and LIME analysis that were conducted on the best-performing model highlighted key features related to dental manifestations and respiratory infections which are commonly presented in MPS patients, such as acute gingivitis, accretions on teeth, dental caries, acute pharyngitis, acute tonsillitis, and acute bronchitis. This study introduces a cost-effective screening approach for MPS disease using non-invasive EHR, which contributes to the advances in digital screening tools for the early diagnosis of rare diseases.- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Open AccessComparison of machine learning models for mucopolysaccharidosis early diagnosis using UAE medical records
Rare diseases, such as Mucopolysaccharidosis (MPS), present significant challenges to the healthcare system. Some of the most critical challenges are the delay and the lack of accurate disease diagnosis. Early diagnosis of MPS is crucial, as it has the potential to significantly improve patients’ response to treatment, thereby reducing the risk of complications or death. This study evaluates the performance of different machine learning (ML) models for MPS diagnosis using electronic health records (EHR) from the Abu Dhabi Health Services Company (SEHA). The retrospective cohort comprises 115 registered patients aged \(\le\) 19 Years old from 2004 to 2022. Using nested cross-validation, we trained different feature selection algorithms in combination with various ML algorithms and evaluated their performance with multiple evaluation metrics. Finally, the best-performing model was further interpreted using feature contributions analysis methods such as Shapley additive explanations (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME). We found that Naive Bayes trained on the domain expert selected features reported a superior performance with an accuracy of 0.93 (0.08), AUC of 0.96 (0.04), F1-score of 0.91 (0.1), and MCC of 0.86 (0.16). SHAP and LIME analysis that were conducted on the best-performing model highlighted key features related to dental manifestations and respiratory infections which are commonly presented in MPS patients, such as acute gingivitis, accretions on teeth, dental caries, acute pharyngitis, acute tonsillitis, and acute bronchitis. This study introduces a cost-effective screening approach for MPS disease using non-invasive EHR, which contributes to the advances in digital screening tools for the early diagnosis of rare diseases. - Open Access
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Alzheimer’s disease risk prediction using machine learning for survival analysis with a comorbidity-based approach
Alzheimer’s disease (AD) presents a pressing global health challenge, demanding improved strategies for early detection and understanding its progression. In this study, we address this need by employing survival analysis techniques to predict transition time from Cognitive Normal (CN) to Mild Cognitive Impairment (MCI) in elderly individuals, considering the predictive value of baseline comorbidities. Leveraging data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) databases, we construct feature sets encompassing demographics, cognitive scores, and comorbidities. Various machine learning and deep learning methods for survival analysis are employed. Our top-performing model, fast random forest, achieves a concordance index of 0.84 when considering all feature modalities, with comorbidity data emerging as a significant predictor. The top features identified by the best-performing model include one demographic feature (age), seven cognitive scores (ADAS13, RAVLT learning, FAQ, ADAS11, RAVLT immediate, CDRSB, ADASQ4), and two comorbidities (Endocrine & Metabolic, Renal & Genitourinary). Age is highlighted as the most influential predictor, while cognitive scores are crucial indicators of Alzheimer’s disease. External validation against the AIBL dataset affirms the robustness of our approach. Overall, our study contributes to a deeper understanding of the role of baseline comorbidities in AD risk prediction and emphasizes the importance of incorporating comprehensive feature assessment in clinical practice for early diagnosis and personalized treatment planning.
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Open AccessAlzheimer’s disease risk prediction using machine learning for survival analysis with a comorbidity-based approach
Alzheimer’s disease (AD) presents a pressing global health challenge, demanding improved strategies for early detection and understanding its progression. In this study, we address this need by employing survival analysis techniques to predict transition time from Cognitive Normal (CN) to Mild Cognitive Impairment (MCI) in elderly individuals, considering the predictive value of baseline comorbidities. Leveraging data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) databases, we construct feature sets encompassing demographics, cognitive scores, and comorbidities. Various machine learning and deep learning methods for survival analysis are employed. Our top-performing model, fast random forest, achieves a concordance index of 0.84 when considering all feature modalities, with comorbidity data emerging as a significant predictor. The top features identified by the best-performing model include one demographic feature (age), seven cognitive scores (ADAS13, RAVLT learning, FAQ, ADAS11, RAVLT immediate, CDRSB, ADASQ4), and two comorbidities (Endocrine & Metabolic, Renal & Genitourinary). Age is highlighted as the most influential predictor, while cognitive scores are crucial indicators of Alzheimer’s disease. External validation against the AIBL dataset affirms the robustness of our approach. Overall, our study contributes to a deeper understanding of the role of baseline comorbidities in AD risk prediction and emphasizes the importance of incorporating comprehensive feature assessment in clinical practice for early diagnosis and personalized treatment planning.
- 27 June 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 145-149
Sagittal Reaction Moments During Gait using Kinematic Inputs: A Deep Learning Approach
Accurate estimation of joint reaction moments (JRMs) and ground reaction moments (GRMs) during gait is critical for diagnosing musculoskeletal disorders but remains constrained by lab-dependent methods requiring force plates or full-body kinematics. This study introduces a novel deep learning framework to predict sagittal plane JRMs and GRMs using only single-marker positional data (hip, knee, ankle), eliminating the need for complex instrumentation. Leveraging sequence-to-sequence models (GRU, LSTM, 1D-CNN) optimized via Bayesian hyperparameter tuning and Leave-One-Subject-Out (LOSO) cross-validation, we analyzed gait data from 80 asymptomatic adults. Models achieved RMSE values of $31.1-50.1 \text{Nmm} / \text{kg}$ across joints, with normalized RMSE (nRMSE) between $\mathbf{1 6} \boldsymbol{-} \mathbf{2 1 {\%}}$, comparable to prior studies using more extensive inputs. GRU excelled at ankle moment prediction $(31.1 \pm 25.8$ vs. $38.6 \pm 30.0$ Nmm/kg, left/right), while LSTM showed robustness for knee moments $(35.0 \pm 25.6$ vs. $37.2 \pm 30.1 \text{Nmm} / \text{kg})$. Asymmetries in hip RMSE $(48.7 \pm 25.7 \mathrm{L}$ vs. $42.4 \pm 23.4 \mathrm{R})$ highlighted joint-specific variability. The framework's minimal kinematic requirements reduce computational burden, offering a scalable alternative to traditional gait analysis. Despite strong performance in asymptomatic individuals, validation in pathological populations and integration with Markerless systems are needed for clinical translation. This work advances accessible, lab-free biomechanical assessment, demonstrating the potential of deep learning to bridge gaps between research and clinical practice.- 27 June 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 145-149
Sagittal Reaction Moments During Gait using Kinematic Inputs: A Deep Learning Approach
Accurate estimation of joint reaction moments (JRMs) and ground reaction moments (GRMs) during gait is critical for diagnosing musculoskeletal disorders but remains constrained by lab-dependent methods requiring force plates or full-body kinematics. This study introduces a novel deep learning framework to predict sagittal plane JRMs and GRMs using only single-marker positional data (hip, knee, ankle), eliminating the need for complex instrumentation. Leveraging sequence-to-sequence models (GRU, LSTM, 1D-CNN) optimized via Bayesian hyperparameter tuning and Leave-One-Subject-Out (LOSO) cross-validation, we analyzed gait data from 80 asymptomatic adults. Models achieved RMSE values of $31.1-50.1 \text{Nmm} / \text{kg}$ across joints, with normalized RMSE (nRMSE) between $\mathbf{1 6} \boldsymbol{-} \mathbf{2 1 {\%}}$, comparable to prior studies using more extensive inputs. GRU excelled at ankle moment prediction $(31.1 \pm 25.8$ vs. $38.6 \pm 30.0$ Nmm/kg, left/right), while LSTM showed robustness for knee moments $(35.0 \pm 25.6$ vs. $37.2 \pm 30.1 \text{Nmm} / \text{kg})$. Asymmetries in hip RMSE $(48.7 \pm 25.7 \mathrm{L}$ vs. $42.4 \pm 23.4 \mathrm{R})$ highlighted joint-specific variability. The framework's minimal kinematic requirements reduce computational burden, offering a scalable alternative to traditional gait analysis. Despite strong performance in asymptomatic individuals, validation in pathological populations and integration with Markerless systems are needed for clinical translation. This work advances accessible, lab-free biomechanical assessment, demonstrating the potential of deep learning to bridge gaps between research and clinical practice.- Open Access
- 15 May 2025
- Published by Elsevier in Neurocomputing
- Vol. 642
Robust fMRI time-varying functional connectivity analysis using multivariate swarm decomposition
- 15 May 2025
- Published by Elsevier in Neurocomputing
- Vol. 642
Open AccessRobust fMRI time-varying functional connectivity analysis using multivariate swarm decomposition
- Open Access
- 14 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0320360
c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder that requires early diagnosis for effective management. However, issues with currently available diagnostic biomarkers preclude early diagnosis, necessitating the development of alternative biomarkers and methods, such as blood-based diagnostics. We propose c-Triadem (constrained triple-input Alzheimer’s disease model), a novel deep neural network to identify potential blood-based biomarkers for AD and predict mild cognitive impairment (MCI) and AD with high accuracy. The model utilizes genotyping data, gene expression data, and clinical information to predict the disease status of participants, i.e., cognitively normal (CN), MCI, or AD. The nodes of the neural network represent genes and their related pathways, and the edges represent known relationships among the genes and pathways. Simulated data validation further highlights the robustness of key features identified by SHapley Additive exPlanations (SHAP). We trained the model with blood genotyping data, microarray, and clinical features from the Alzheimer’s Neuroimaging Disease Initiative (ADNI). We demonstrate that our model’s performance is superior to previous models with an AUC of 97% and accuracy of 89%. We then identified the most influential genes and clinical features for prediction using SHapley Additive exPlanations (SHAP). Our SHAP analysis shows that CASP9, LCK, and SDC3 SNPs and PINK1, ATG5, and ubiquitin (UBB, UBC) expression have a higher impact on model performance. Our model has facilitated the identification of potential blood-based genetic markers of DNA damage response and mitophagy in affected regions of the brain. The model can be used for detection and biomarker identification in other related dementias.
- 14 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0320360
Open Accessc-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder that requires early diagnosis for effective management. However, issues with currently available diagnostic biomarkers preclude early diagnosis, necessitating the development of alternative biomarkers and methods, such as blood-based diagnostics. We propose c-Triadem (constrained triple-input Alzheimer’s disease model), a novel deep neural network to identify potential blood-based biomarkers for AD and predict mild cognitive impairment (MCI) and AD with high accuracy. The model utilizes genotyping data, gene expression data, and clinical information to predict the disease status of participants, i.e., cognitively normal (CN), MCI, or AD. The nodes of the neural network represent genes and their related pathways, and the edges represent known relationships among the genes and pathways. Simulated data validation further highlights the robustness of key features identified by SHapley Additive exPlanations (SHAP). We trained the model with blood genotyping data, microarray, and clinical features from the Alzheimer’s Neuroimaging Disease Initiative (ADNI). We demonstrate that our model’s performance is superior to previous models with an AUC of 97% and accuracy of 89%. We then identified the most influential genes and clinical features for prediction using SHapley Additive exPlanations (SHAP). Our SHAP analysis shows that CASP9, LCK, and SDC3 SNPs and PINK1, ATG5, and ubiquitin (UBB, UBC) expression have a higher impact on model performance. Our model has facilitated the identification of potential blood-based genetic markers of DNA damage response and mitophagy in affected regions of the brain. The model can be used for detection and biomarker identification in other related dementias.
- Open Access
- 27 December 2024
- Published by Springer Nature in Research Square
Revolutionizing Disease Diagnosis with Large Language Models: A Systematic Review
Purpose: The underlining success of large language models (LLMs) in general language understanding has revolutionized many domains, including healthcare. This systematic review aims to explore the application of LLM in disease diagnosis, acknowledging its success in reducing diagnosis delays in areas with limited health resources or when health costs are not affordable. Methods: We systematically reviewed the literature on LLMs used for disease diagnosis tasks, such as differential diagnosis, question-answering, and report generation, from January 2014 to September 2024. The included studies are categorized based on input data types (text, images, others), learning approaches (zero-shot, few-shot, retrieval-augmented generation, fine-tuning, etc.), and diagnostic contexts. Results: We observe that LLMs used for disease diagnosis primarily employ zero-shot learning, prompting, and retrieval-augmented generation techniques. While some LLMs are explicitly fine-tuned for this purpose, only a few have been trained from scratch. Most LLMs are trained using data from the Internet and research publications. Despite this, LLM models have successfully diagnosed many common chronic diseases and addressed some rare and uncommon diseases with reasonable accuracy. Despite these promising trends and successes, concerns about the potential for misdiagnosis persist, particularly with less common and rare diseases. Conclusion: The use of LLMs in disease diagnosis has a promising future in reducing diagnostic delay and complementing the work of health professionals in resource-constrained environments. The success of LLM in disease diagnosis calls for proper analysis of data from health domains and for encouraging the inclusion of information on otherwise uncommon diseases.
- 27 December 2024
- Published by Springer Nature in Research Square
Open AccessRevolutionizing Disease Diagnosis with Large Language Models: A Systematic Review
Purpose: The underlining success of large language models (LLMs) in general language understanding has revolutionized many domains, including healthcare. This systematic review aims to explore the application of LLM in disease diagnosis, acknowledging its success in reducing diagnosis delays in areas with limited health resources or when health costs are not affordable. Methods: We systematically reviewed the literature on LLMs used for disease diagnosis tasks, such as differential diagnosis, question-answering, and report generation, from January 2014 to September 2024. The included studies are categorized based on input data types (text, images, others), learning approaches (zero-shot, few-shot, retrieval-augmented generation, fine-tuning, etc.), and diagnostic contexts. Results: We observe that LLMs used for disease diagnosis primarily employ zero-shot learning, prompting, and retrieval-augmented generation techniques. While some LLMs are explicitly fine-tuned for this purpose, only a few have been trained from scratch. Most LLMs are trained using data from the Internet and research publications. Despite this, LLM models have successfully diagnosed many common chronic diseases and addressed some rare and uncommon diseases with reasonable accuracy. Despite these promising trends and successes, concerns about the potential for misdiagnosis persist, particularly with less common and rare diseases. Conclusion: The use of LLMs in disease diagnosis has a promising future in reducing diagnostic delay and complementing the work of health professionals in resource-constrained environments. The success of LLM in disease diagnosis calls for proper analysis of data from health domains and for encouraging the inclusion of information on otherwise uncommon diseases.